Risk of lung cancer in Parkinson’s disease

Xin Xie; Xiaoguang Luo; Mingliang Xie; Yang Liu; Ting Wu

doi:10.18632/oncotarget.12964

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Risk of lung cancer in Parkinson’s disease

Xin Xie, Xiaoguang Luo _, Mingliang Xie, Yang Liu and Ting Wu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:77319-77325. https://doi.org/10.18632/oncotarget.12964

Metrics: PDF 2465 views | HTML 1954 views | ?

Abstract

Xin Xie1, Xiaoguang Luo1, Mingliang Xie2, Yang Liu1, Ting Wu1

1Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang City 110001, PR China

2Clinics of the People’s Armed Police Command College, Tianjin City, 300000, PR China

Correspondence to:

Xiaoguang Luo, email: [email protected]

Keywords: lung neoplasms, meta-analysis, Parkinson’s disease, risk

Received: September 14, 2016 Accepted: October 14, 2016 Published: October 27, 2016

ABSTRACT

Recently, growing evidence has revealed the significant association between Parkinson’s disease (PD) and cancer. However, controversy still exists concerning the association between PD and lung cancer. A comprehensive article search for relevant studies published was performed using the following online databases: PubMed, Web of Science and Embase up to August 31, 2016. The pooled risk ratio (RR) and their 95 % confidence intervals (CI) were calculated using the method of inverse variance with the random-effects model. Fifteen studies comprising 348,780 PD patients were included in this study. The pooled result indicated that patients with PD were significantly associated with a decreased risk of lung cancer (RR: 0.53, 95% CI: 0.41−0.70, P < 0.001). In addition, subgroup analyses performed in Western population also confirmed the significant inverse relationship between PD and risk of lung cancer (RR: 0.48, 95% CI: 0.39−0.60, P < 0.001). In the subgroup analysis, a reduced risk of lung cancer in PD patients from Western population was consistent regardless of study design, gender, or study quality. In conclusion, PD patients were significantly associated with a reduced risk of lung cancer in Western population. The relationship between them in Asian population needs to be confirmed by future studies.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12964

Publication Alerts

Research Papers:

Risk of lung cancer in Parkinson’s disease

Abstract